Clinical Trial Update: Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating Envafolimab in combination with chemotherapy for metastatic or recurrent gastric adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• Envafolimab (envafolimab)

Snippet

Sponsor: Liangjun Zhu M.M. | Conditions: Metastatic or Recurrent Gastric Adenocarcinoma | Phase 2 | Status: UNKNOWN